Nav1.8 subtype selective blockers are predicted to be effective in the treatment of neuropathic pain and to be associated with fewer adverse effects than currently available therapies. Drugs for the clinical treatment of neuropathic pain can interact with other members of the voltage-gated sodium channel (Nav1) family due to their close sequence homology.
Product Information | |
---|---|
Catalog #: | ACC-RI0055 |
Gene Name: | Nav1.8 |
Abbr | ND7-23-RatNav1.8 |
Channel Type | Sodium Channel |
Growth Properties | Adherent |
Host Cell | ND7-23 |
Morphology | Neuronal |
Product Format | frozen |
Product Type | Ion Channel Expressing Cell |
Shipping | Dry ice |
Species | Rat |
Inquiry